Ohad Shimshon Bentur (O S Bentur, Ohad Bentur, Ohad S Bentur)

Years Active: 2017-2021
Publications (10 Years): 5

Rockefeller University

Ben-Gurion University of the Negev (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Rockefeller University

United States

Clinical Scholar / Instructor in clinical Investigation :: The Laboratory of Blood and Vascular Research

Education History

Ben-Gurion University of the Negev

Israel

MSC :: Guilford Glazer Faculty of Business & Management

Publications

Lorena Buitrago, Samuel Lefkowitz, Ohad Shimshon Bentur, Julio Padovan, Barry S Coller
Platelet binding to polymerizing fibrin is avidity driven and requires activated αIIbβ3 but not fibrin cross-linking. Blood advances 5 (20) (2021)
Ohad Shimshon Bentur, Jihong Li, Caroline S Jiang, Linda H Martin, Dean J Kereiakes, Barry S Coller
Application of Auxiliary VerifyNow Point-of-Care Assays to Assess the Pharmacodynamics of RUC-4, a Novel αIIbβ3 Receptor Antagonist. TH open : companion journal to thrombosis and haemostasis 5 (3) (2021)
Ohad Shimshon Bentur, E J Dann, E Paran, D Lavie, B Nachmias, Y Ron, N Dally, O Gutwein, Y Herishanu, N Sarid, I Avivi, Chava Perry
Interim PET-CT-guided therapy in elderly patients with Hodgkin lymphoma-a retrospective national multi-center study. Annals of hematology 98 (7) (2019)
Yakir Moshe, Ohad Shimshon Bentur, Michael Lishner, Irit Avivi
The management of hodgkin lymphomas in pregnancies. European journal of haematology 99 (5) (2017)
Ohad Shimshon Bentur, Ronit Gurion, Anat Gafter-Gvili, Moshe Gatt, Lev Shvidel, Netanel A Horowitz, Ron Ram, Yair Herishanu, Nadav Sarid, Ora Paltiel, Chezi Ganzel, Natalia Kreiniz, Najib Dally, Odit Gutwein, Pia Raanani, Irit Avivi, Chava Perry
Treatment and prognosis of stage I follicular lymphoma in the modern era - does PET matter? Leukemia & lymphoma 59 (5) (2017)

Ohad Shimshon Bentur.css-eqlu8i{font-size:small;padding-left:4px;} (O S Bentur, Ohad Bentur, Ohad S Bentur)